华润医药(03320.HK) 宣布，旗下东阿阿胶受邀出席由新西兰政府主办的“新西兰政府与中国重点合作伙伴签约仪式”，并与新西兰鹿业局于6月18日在上海举行的签约仪式上正式签署《合作备忘录》。
华润医药指，新西兰作为全球鹿产业领先国家，拥有超过80万头赤鹿存栏量及完善的产业链体系，其鹿制品以纯天然饲养和高标准可溯源著称。
东阿阿胶作为集团中药大健康板块的重要成员，推出“皇家围场1619”品牌，瞄准以鹿产业为代表的健康消费新赛道作出前瞻性部署。未来，东阿阿胶将与新西兰政府及当地企业进行更加深入的合作，整合全球资源，围绕鹿茸等鹿副产品深加工、国际贸易，以及鹿茸药材国际准入等问题开展全面探索，提升鹿产品研发能力，共同拓展国际市场份额。(sl/da)(港股报价延迟最少十五分钟。沽空资料截至 2025-06-19 16:25。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.